Accelerating BPC-PaCo through Visually Lossless Techniques

Fast image codecs are a current need in applications that deal with large amounts of images. Graphics Processing Units (GPUs) are suitable processors to speed up most kinds of algorithms, especially when they allow fine-grain parallelism. Bitplane Coding with Parallel Coefficient processing (BPC-PaCo) is a recently proposed algorithm for the core stage of wavelet-based image codecs tailored for the highly parallel architectures of GPUs. This algorithm provides complexity scalability to allow faster execution at the expense of coding efficiency. Its main drawback is that the speedup and loss in image quality is controlled only roughly, resulting in visible distortion at low and medium rates. This paper addresses this issue by integrating techniques of visually lossless coding into BPC-PaCo. The resulting method minimizes the visual distortion introduced in the compressed file, obtaining higher-quality images to a human observer. Experimental results also indicate 12% speedups with respect to BPC-PaCo.     

基于推理注意力机制的二阶段网络图像修复

现有的图像修复方法在处理大面积缺失或高度纹理化的图像时，通常会产生扭曲的结构或与周围区域不一致的模糊纹理，无法重建合理的图像结构。为此，提出了一种基于推理注意力机制的二阶段网络图像修复方法。首先通过边缘生成网络生成合理的幻觉边缘信息，然后在图像补全网络完成图像的重建工作。为了进一步生成视觉效果更逼真的图像，提高图像修复的精确度，在图像补全网络采用推理注意力机制，有效控制了生成特征的不一致性，从而生成更有效的信息。所提方法在多个数据集上进行了实验验证，结果表明该图像修复方法的结构相似性指数达到了88.9%，峰值信噪比达到了25.56 dB，与现有的图像修复方法相比，该方法具有更高的图像修复精确度，生成的图像更逼真。     

基于机器视觉的轮胎表面缺陷检测系统的研究与应用

在传统的轮胎表面缺陷依靠人工检测,存在劳动强度高、受人的主观影响大以及效率低下的问题。针对这一现象,研究了一种基于机器视觉的轮胎表面缺陷3D检测系统。该系统依靠机器视觉系统获取检测轮胎的表面图像,然后创建3D模型、判定缺陷类型,最终实现实时自动预警,为轮胎生产商提供一种自动化检测方案。系统集成了先进的技术、软件和工具,配套的信息管控系统可以对轮胎型号和生产数据进行采集、存储、分析,以便在生产过程中实现更高效、更可靠的质量控制,具有较高的实际应用推广价值。     

成型温度对PBX装药内部质量及性能的影响

针对压制成型的PBX炸药装药，选择CT无损检测、巴西实验和扫描电镜检测等技术，对比研究了室温和加热两种温度下压制成型的炸药装药内部质量、静态力学性能和细观破坏形式。结果表明，加热压制有利于改善炸药装药的内部质量，可避免产生初始损伤，且提高了装药的力学性能。细观尺度上，室温压制成型的装药主要发生界面脱黏破坏，加热压制成型装药的主要破坏形式是穿晶断裂。     

AQP3 Increases Intercellular Cohesion in NSCLC A549 Cell Spheroids through Exploratory Cell Protrusions

Tumor cell aggregation is critical for cell survival following the loss of extracellular matrix attachment and dissemination. However, the underlying mechanotransduction of clustering solitary tumor cells is poorly understood, especially in non-small cell lung cancers (NSCLC). Here, we examined whether cell surface protrusions played an important role in facilitating the physical contact between floating cells detached from a substrate. We employed poly-2-hydroxyethyl methacrylate-based 3D culture methods to mimic in vivo tumor cell cluster formation. The suprastructural analysis of human NSCLC A549 cell spheroids showed that finger-like protrusions clung together via the actin cytoskeleton. Time-lapse holotomography demonstrated that the finger-like protrusions of free-floating cells in 3D culture displayed exploratory coalescence. Global gene expression analysis demonstrated that the genes in the organic hydroxyl transport were particularly enriched in the A549 cell spheroids. Particularly, the knockdown of the water channel aquaporin 3 gene (AQP3) impaired multicellular aggregate formation in 3D culture through the rearrangement of the actomyosin cytoskeleton. Moreover, the cells with reduced levels of AQP3 decreased their transmigration. Overall, these data indicate that cell detachment-upregulated AQP3 contributes to cell surface protrusions through actomyosin cytoskeleton remodeling, causing the aggressive aggregation of free-floating cells dependent on the property of the substratum and collective metastasis.     

多模态影像学检查在诊断早期强直性脊柱炎骶髂关节疾病中的效果

目的:探究在早期强直性脊柱炎骶髂关节疾病诊断中不同放射影像学检查方法的应用效果。方法:抽取2018年5月-2020年1月本院收治的早期强直性脊柱炎骶髂关节疾病患者65例作为研究对象,所有患者均开展X线、CT、MRI影像学检查,对比三种不同影像学检查方法的检出率、影像学特征。结果:X线、CT、MRI检出率分别为38.46%(25/65)、60.00%(39/65)、76.92%(50/65),检出率相比,MRI、CT明显高于X线,P<0.05;X线、CT、MRI影像学特征,发现关节间隙出现不同的异常,如关节面出现侵蚀、骨质囊变现象,关节面下骨质出现硬化与关节软骨出现肿胀,其中MRI、CT检查,阳性率高于X线,P<0.05。而对于软组织肿胀、骨髓水肿、滑膜炎症、关节滑膜增厚等现象,只能通过MRI检查才能诊断。结论:在早期强直性脊柱炎骶髂关节疾病诊断中,X线、CT、MRI影像学检查均具有一定的指导意义,而MRI不仅可以提高检出率,还能准确反映微小病灶及其软组织病变,对于早期发现骶髂关节炎值得推荐。     

印刷电路板缺陷检测的实际应用

电路板在我们的日常生活中非常常见,这就使得印刷电路板的缺陷检测显得尤为重要。AOI作为新兴的检测PCB板缺陷的系统,在生产实际中正在被大家熟知并且应用。相较于传统的检测方式,AOI系统比较灵活,无论是在检测时间还是系统运算上,或者是对相关技术人员的要求相较于传统方式都比较有优势,本文就AOI系统在实际中的应用展开讨论,分析并且介绍了在实际应用中的具体细则。     

Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma

Lung cancer is one of the most common malignant neoplasms. As a result of the disease’s progression, patients may develop metastases to the central nervous system. The prognosis in this location is unfavorable; untreated metastatic lesions may lead to death within one to two months. Existing therapies—neurosurgery and radiation therapy—do not improve the prognosis for every patient. The discovery of Epidermal Growth Factor Receptor (EGFR)—activating mutations and Anaplastic Lymphoma Kinase (ALK) rearrangements in patients with non-small cell lung adenocarcinoma has allowed for the introduction of small-molecule tyrosine kinase inhibitors to the treatment of advanced-stage patients. The Epidermal Growth Factor Receptor (EGFR) is a transmembrane protein with tyrosine kinase-dependent activity. EGFR is present in membranes of all epithelial cells. In physiological conditions, it plays an important role in the process of cell growth and proliferation. Binding the ligand to the EGFR causes its dimerization and the activation of the intracellular signaling cascade. Signal transduction involves the activation of MAPK, AKT, and JNK, resulting in DNA synthesis and cell proliferation. In cancer cells, binding the ligand to the EGFR also leads to its dimerization and transduction of the signal to the cell interior. It has been demonstrated that activating mutations in the gene for EGFR-exon19 (deletion), L858R point mutation in exon 21, and mutation in exon 20 results in cancer cell proliferation. Continuous stimulation of the receptor inhibits apoptosis, stimulates invasion, intensifies angiogenesis, and facilitates the formation of distant metastases. As a consequence, the cancer progresses. These activating gene mutations for the EGFR are present in 10–20% of lung adenocarcinomas. Approximately 3–7% of patients with lung adenocarcinoma have the echinoderm microtubule-associated protein-like 4 (EML4)/ALK fusion gene. The fusion of the two genes EML4 and ALK results in a fusion gene that activates the intracellular signaling pathway, stimulates the proliferation of tumor cells, and inhibits apoptosis. A new group of drugs—small-molecule tyrosine kinase inhibitors—has been developed; the first generation includes gefitinib and erlotinib and the ALK inhibitor crizotinib. These drugs reversibly block the EGFR by stopping the signal transmission to the cell. The second-generation tyrosine kinase inhibitor (TKI) afatinib or ALK inhibitor alectinib block the receptor irreversibly. Clinical trials with TKI in patients with non-small cell lung adenocarcinoma with central nervous system (CNS) metastases have shown prolonged, progression-free survival, a high percentage of objective responses, and improved quality of life. Resistance to treatment with this group of drugs emerging during TKI therapy is the basis for the detection of resistance mutations. The T790M mutation, present in exon 20 of the EGFR gene, is detected in patients treated with first- and second-generation TKI and is overcome by Osimertinib, a third-generation TKI. The I117N resistance mutation in patients with the ALK mutation treated with alectinib is overcome by ceritinib. In this way, sequential therapy ensures the continuity of treatment. In patients with CNS metastases, attempts are made to simultaneously administer radiation therapy and tyrosine kinase inhibitors. Patients with lung adenocarcinoma with CNS metastases, without activating EGFR mutation and without ALK rearrangement, benefit from immunotherapy. This therapeutic option blocks the PD-1 receptor on the surface of T or B lymphocytes or PD-L1 located on cancer cells with an applicable antibody. Based on clinical trials, pembrolizumab and all antibodies are included in the treatment of non-small cell lung carcinoma with CNS metastases.     

A novel fusion paradigm for multi-channel image denoising

Multi-channel and single-channel image denoising are on two important development fronts. Integrating multi-channel and single-channel image denoisers for further improvement is a valuable research direction. A natural assumption is that using more useful information is helpful to the output results. In this paper, a novel multi-channel and single-channel fusion paradigm (MSF) is proposed. The proposed MSF works by fusing the estimates of a multi-channel image denoiser and a single-channel image denoiser. The performance of recent multi-channel image denoising methods involved in the proposed MSF can be further improved at low additional time-consuming cost. Specifically, the validity principle of the proposed MSF is that the fused single-channel image denoiser can produce auxiliary estimate for the involved multi-channel image denoiser in a designed underdetermined transform domain. Based on the underdetermined transformation, we create a corresponding orthogonal transformation for fusion and better restore the multi-channel images. The quantitative and visual comparison results demonstrate that the proposed MSF can be effectively applied to several state-of-the-art multi-channel image denoising methods.     

水下图像处理技术研究综述

随着自主式水下机器人的发展，水下探测技术成为新的研究热点。然而，吸收效应和散射效应导致水下获取的图像存在雾化和色彩偏差等缺陷。降质的水下图像在一定程度上降低了水下目标识别的准确性。为了改善水下图像质量，国内外学者对水下图像处理方法进行了深入研究。因水下图像处理方法对提升水下目标识别准确性具有良好的促进作用，故其具有重要的研究与分析价值。介绍了水下成像模型，分析了水下图像视觉质量下降的原理；根据水下物理成像模型将水下图像处理方法分为水下图像增强与水下图像复原，并分别对两类方法的研究现状进行分析与归纳；最后，总结与讨论了各类方法的优缺点，并展望了未来的发展方向。